High-resolution melting PCR assay as a powerful tool for the epidemiological surveillance of tularemia in Western Europe.


Journal

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
ISSN: 1567-7257
Titre abrégé: Infect Genet Evol
Pays: Netherlands
ID NLM: 101084138

Informations de publication

Date de publication:
06 2021
Historique:
received: 31 07 2020
revised: 14 12 2020
accepted: 26 01 2021
pubmed: 9 2 2021
medline: 12 1 2022
entrez: 8 2 2021
Statut: ppublish

Résumé

In Europe, tularemia is caused by Francisella tularensis subsp. holarctica and is a sporadic disease affecting mainly wildlife animals and humans. Classification of this species relies on canonical single nucleotide polymorphisms (canSNPs). Four main clades have been described for F. tularensis subsp. holarctica: B.4, B.6, B.12 and B.16. Phylogeographic studies have shown that clade B.6 is predominant in Western Europe and B.12 in Eastern and Central Europe. Based on this global phylogeny, we aimed to design a molecular typing assay for all genetic subclades of subclade B.11, which is the predominant subclade in clade B.6. We designed high-resolution melting (HRM) primers for the screening of 109 canSNPs divided in seven orders of discrimination for the molecular epidemiology analysis and tracking of Francisella tularensis subsp. holarctica in Western Europe.

Identifiants

pubmed: 33556556
pii: S1567-1348(21)00038-1
doi: 10.1016/j.meegid.2021.104741
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104741

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Maëllys Kevin (M)

Paris-Est University/ANSES, Animal Health Laboratory, Maisons-Alfort, France.

Guillaume Girault (G)

Paris-Est University/ANSES, Animal Health Laboratory, Maisons-Alfort, France.

Yvan Caspar (Y)

Laboratoire de Bactériologie-Hygiène hospitalière, Centre National de Référence des Francisella, CHU-Grenoble-Alpes, Grenoble, France.

Moulay Ali Cherfa (MA)

Paris-Est University/ANSES, Animal Health Laboratory, Maisons-Alfort, France.

Christiane Mendy (C)

Paris-Est University/ANSES, Animal Health Laboratory, Maisons-Alfort, France.

Max Maurin (M)

Laboratoire de Bactériologie-Hygiène hospitalière, Centre National de Référence des Francisella, CHU-Grenoble-Alpes, Grenoble, France.

Claire Ponsart (C)

Paris-Est University/ANSES, Animal Health Laboratory, Maisons-Alfort, France.

Nora Madani (N)

Paris-Est University/ANSES, Animal Health Laboratory, Maisons-Alfort, France. Electronic address: Nora.madani@anses.fr.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Glycogen Storage Disease Type II Humans Critical Pathways Europe

Total elbow arthroplasty in England.

Zaid Hamoodi, Adrian Sayers, Michael R Whitehouse et al.
1.00
Humans England Female Male Arthroplasty, Replacement, Elbow

UK Foot and Ankle Thromboembolism (UK-FATE).

Jitendra Mangwani, Linzy Houchen-Wolloff, Karan Malhotra et al.
1.00
Humans Venous Thromboembolism Male Female United Kingdom

Classifications MeSH